Parkinson’s fought by restoring protein cleanup
In Parkinson’s disease, one damaging protein accumulates inside nerve cells. Researchers have now uncovered a mechanism that can clear it. The finding opens a new avenue for treatment.
Parkinson’s disease is characterised by clumps of a protein called alpha-synuclein. These clumps build up inside neurons and eventually damage them. What drives that accumulation has been the subject of research for years.
The researchers explained how a protein found in both yeast and humans facilitates the breakdown of alpha-synuclein. This process falls under what biologists call proteostasis: a cell’s ability to correctly produce, fold and also degrade proteins. As we age, that balance is disrupted. Misfolded proteins accumulate and the clearance machinery becomes less effective.
A shared mechanism across evolution
The fact that the identified protein also exists in yeast points to an evolutionarily ancient mechanism. That matters: processes conserved across such vast evolutionary distances tend to be essential for cell function. It suggests this clearance mechanism is fundamental and may play a role in multiple diseases involving protein misfolding.
From laboratory to treatment
The study describes the mechanism at a molecular level. Whether this will directly lead to a drug is not yet known. Clinical applications require further validation. From a longevity perspective, the broader context is relevant: loss of proteostasis is considered one of the core mechanisms of aging. Understanding how cells clear proteins could contribute to treatments for multiple age-related conditions.
The study was reported on Lifespan.io, a research journalism platform focused on aging. The underlying research is peer-reviewed, though the specific journal is not mentioned in the source text.